Below are my comments on the guidelines that you can forward along. So it looks like the market has digested the outcome of the election for the most part. I still think there is going to be a tug of war in terms of COVID with the vaccine news pushing the post-COVID names but […]
August 4th Biotech (and MLP) Update
Well, that was quite the bounce yesterday. The morning start off well especially given the lack of market moving news but then a grind higher turned into a run. I would look at the highs of July 27th and July 28th as key levels. Despite the great move, if we cannot break above those levels […]
June 16th Biotech Update
Interesting market. It seemed clear that the sell off was COVID related as we saw the vaccine names as well as the PPE names outperform (and remain green) during the recent selling. In my mind that added some support to the idea that the support levels in the market might not hold. Yesterday we saw […]
June 9th Biotech (and MLP) Update
Not much to talk about today after yesterday relative flood of news. The sector remains in its range and despite the negative start, the sector did make a move higher towards the upper end of its range. The market in general appears disconnected from the economic fundamentals (at least that is the twitter consensus) but […]
February 28th Biotech Update
We in a macro market. COVID days up and COVID days down. I think it is going to be difficult to find stocks that run counter to the macro moves, ie there will be days when the market moves higher and COIVD names lower and vice versa. I think the only way to avoid that […]
February 14th Biotech Update
You remember how I believed that the sector was at a decision point and was unlikely to hang out close to the recent highs without breaking out or breaking down? Yes, I remember too and of course that is exactly what seems to have happened. While I remain surprised this happened, it does not change […]
September 11th Biotech Update
(Sorry for the delay. The site worked but we had an issue with posting new articles. It is now fixed) The resilience of the sector is a little surprising and could pay off. It had been looking like a breakdown candidate but never followed through on that potential. Now it is looking like a breakout […]
July 30 Biotech Update
Tell me if you heard this before. Good news in the sector that moves individual stocks and yet little effect on the broader sector. We have yet another day with good news (clinical and earnings) and yet the sector is barely green. Granted the broader market is red but this has become a trend. I […]
May 31 Biotech Update
Macro, Macro, Macro. No this is not a complete repeat of yesterday but it sure is looking like one. It would be really nice to have at least some time without new macro concerns but you trade the market you have not the market you want to have. At the very least we have ASCO […]
May 14 Biotech Update
I am not sure who had a more difficult day yesterday. You all for having to watch another market meltdown over China fears (and others) or me who had to help chaperone a middle school trip to New Orleans. In any case, we have all survived and the market seems to be bouncing this morning. […]
January 29 Biotech Update
An interesting start to large cap earnings. The sector was weak yesterday and this could be the long awaited pullback (or another head fake). Ideally, the pullback bottoms out in the $73-$75 range on the XBI to form a higher low. While a retest of the recent low around $64 is not impossible it would […]
January 7 Biotech Update
This is one hell of a start for biotechs this year. M&A and good data are back. Of course, there is a bias in JPM week to present good news early, so I would be surprised to see this rate of positive news to continue all week but this is certainly a great start and […]
December 13 Biotech Update
Not a ton of news as the year closes down. It seems like the market wants to whiplash investors as we bounce around with no clear trends. It does not matter how strong or weak a day is as it seems to have no impact on trading the next day. We should be approaching a […]
October23 Biotech Update
It is unfortunate that the earnings weeks comes as the market seems to want to collapse. Industrial earnings are finally seeing the impact of the trade policies and now apparently it is a biotech issue. It is hard to see how the sector would avoid being pulled into a larger market sell-off regardless of the […]
October 10 Biotech Update
I do not think there is much to say today outside of the obvious. The market is not looking good and we seem to be entering (or in the midst) of a broad market correction that is going to take everything down with it. Fundamentals are not going to matter in the near term. It […]
August 1 Biotech Update
The sector recovered a little yesterday from last week’s sell-off but ideally we would need to see the sector break into new highs. It seems highly likely that the sector tests the recent highs and the price action at that point is likely to be a strong signal of underlying strength. Given the fundamentals and […]
May 1 Biotech Update
It looks like the market is in dangerous territory but barring some exogenous shock (perhaps war between Iran and Israel as a potential source of shock), it seems more like a long period of sideways trading. All rallies are being sold but the market has enough oversold conditions that it would be difficult to have […]
Dave Trading – April 2018
*** David Sobek is a disciplined value investor. Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.*** As a reminder, this is my personal guide. You can alter it in accordance with your risk tolerance. >3 Standard deviations – No position 2-3 […]
March 19 Biotech Update
The sector continues to struggle a little as we have a lack of leadership and the old leaders are faltering. This morning does not dissuade from this analysis but it is early and the broader market is weak as well. In any case, this week should provide enough data to know whether or not another […]
February 22 Biotech Update
A little pick up in the news flow but clearly the sector has been tied to the broader market in the immediate term. The spike in interest rates caused by the Fed minutes took the market and the sector down. While the direct impact of raising interest rates on the sector is minimal, it does […]
